follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Antares Pharma enters marketing agreement worth up to $20M for psoriasis treatment

By

Back to Top Comments Email Print

News You Can Use

Latest News

    advertisement

    Ewing-based Antares Pharma Inc. announced today its exclusive promotion and marketing agreement with Denmark-based LEO Pharma regarding the latter company's Otrexup psoriasis treatment.

    According to the announcement, Antares will receive a $5 million initial payment and up to $15 million in additional milestone payments. Antares Pharma will record all product revenue associated with future dermatology prescriptions and pay LEO Pharma a percentage of Otrexup net sales generated in dermatology. LEO Pharma will be responsible for promotion and marketing activities in dermatology.

    Antares appointed a new senior vice president for medical earlier this month.

    Share This Story On:

    Write to the Editorial Department at editorial@njbiz.com

    advertisement

    Comments


    Be the first to comment.



    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    advertisement
      
      
    advertisement
      
      
    advertisement
    Back to Top